(NASDAQ: APYX) Apyx Medical's forecast annual revenue growth rate of 5.89% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.65%.
Apyx Medical's revenue in 2025 is $47,902,000.On average, 6 Wall Street analysts forecast APYX's revenue for 2025 to be $1,950,375,397, with the lowest APYX revenue forecast at $1,873,853,345, and the highest APYX revenue forecast at $2,007,891,222. On average, 6 Wall Street analysts forecast APYX's revenue for 2026 to be $2,047,395,110, with the lowest APYX revenue forecast at $1,963,798,306, and the highest APYX revenue forecast at $2,110,150,076.
In 2027, APYX is forecast to generate $2,184,377,614 in revenue, with the lowest revenue forecast at $2,068,734,093 and the highest revenue forecast at $2,280,747,214.